[1] Fakhoury M.Spinal cord injury: overview of experimental approaches used to restore locomotor activity. Rev Neurosci. 2015;26(4):397-405.[2] Meurer WJ, Barsan WG. Spinal cord injury neuroprotection and the promise of flexible adaptive clinical trials. World Neurosurg. 2014;82(3-4):e541-546.[3] Siddall PJ, Middleton JW. Spinal cord injury-induced pain: mechanisms and treatments. Pain Manag. 2015;5(6):493-507.[4] Neirinckx V, Coste C, Rogister B, et al. Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Transl Med. 2013;2(4):284-296.[5] 潘晶晶,陶进皖. 骨髓间充质干细胞对创伤性脑损伤治疗的研究进展[J]. 国际神经病学神经外科学杂志, 2009, 36(5): 423-426.[6] Wang P, Zhang Y, Zhao J, et al. Intramuscular injection of bone marrow mesenchymal stem cells with small gap neurorrhaphy for peripheral nerve repair. Neurosci Lett. 2015;585:119-125.[7] Scheff SW, Saucier DA, Cain ME. A statistical method for analyzing rating scale data: the BBB locomotor score. J Neurotrauma. 2002;19(10):1251-1260.[8] Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1):1-21.[9] 肖庆忠,李浩威,温冠媚,等.大鼠骨髓间质干细胞基本生物学特性的研究[J]. 中国病理生理杂志,2004,20(3):289-294.[10] Arinzeh TL. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications. Foot Ankle Clin. 2005;10(4):651-665.[11] Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213(2):341-347.[12] Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36(4):568-584.[13] Helder MN, Knippenberg M, Klein-Nulend J, et al. Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng. 2007;13(8):1799-1808.[14] Trubiani O, Orsini G, Caputi S, et al.Adult mesenchymal stem cells in dental research: a new approach for tissue engineering. Int J Immunopathol Pharmacol. 2006;19(3):451-460.[15] Lim CY, Han JI, Kim SG, et al. Evaluation of autologous bone marrow-derived mesenchymal stem cells on renal regeneration after experimentally induced acute kidney injury in dogs. Am J Vet Res. 2016;77(2):208-217.[16] Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41-49.[17] Kuo CK, Tuan RS. Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag. 2003;22(5):51-56.[18] Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 2004;10(1-2): 33-41.[19] 代飞,吴军,许建中.两种从骨髓中分离人间充质干细胞方法的比较研究[J].第三军医大学学报,2005,27(16):1631-1633.[20] Encina NR, Billotte WG, Hofmann MC. Immunomagnetic isolation of osteoprogenitors from human bone marrow stroma. Lab Invest. 1999;79(4):449-457.[21] Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 1987;20(3):263-272.[22] Deryugina EI, Müller-Sieburg CE. Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development. Crit Rev Immunol. 1993;13(2):115-150.[23] García-García A, de Castillejo CL, Méndez-Ferrer S. BMSCs and hematopoiesis. Immunol Lett. 2015;168(2):129-135.[24] Deryugina EI, Müller-Sieburg CE. Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development. Crit Rev Immunol. 1993;13(2):115-150.[25] 何少健,陈维平,邝晓聪. 成体大鼠的骨髓间充质干细胞分离和体外培养的初步研究[J]. 广西医科大学学报, 2002, 19(3): 304-306.[26] Shahdadfar A, Frønsdal K, Haug T, et al. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells. 2005; 23(9):1357-1366.[27] Osaka M, Honmou O, Murakami T, et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 2010;1343:226-235. [28] Li L, Lu? G, Wang YF, et al. Glial cell-derived neurotrophic factor mRNA expression in a rat model of spinal cord injury following bone marrow stromal cell transplantation. Neural Regen Res. 2008;3(10):1056-1059.[29] Wang Q, Sun G, Gao C, et al. Bone marrow mesenchymal stem cells attenuate 2,5-hexanedione-induced neuronal apoptosis through a NGF/AKT-dependent pathway. Sci Rep. 2016;6:34715. [30] Mead B, Berry M, Logan A, et al. Stem cell treatment of degenerative eye disease. Stem Cell Res. 2015;14(3):243-257.[31] Josse C, Schoemans R, Niessen NA, et al. Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2010;19(8):1167-1173.[32] Fröhling S, Döhner H. Chromosomal abnormalities in cancer. N Engl J Med. 2008;359(7):722-734.[33] 宋轶,马坚妹.脊髓损伤动物模型建立方法的分析与比较[J].解剖科学进展,2013,19(4): 366-369,373.[34] Raineteau O, Schwab ME. Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci. 2001;2(4): 263-273.[35] Blight AR.Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology.J Neurol Sci. 1991;103(2):156-171.[36] Joshi M, Fehlings MG.Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma. 2002;19(2):175-190.[37] Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139(2):244-256.[38] Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol. 1995;132(2): 220-228. |